Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
Looking Back on 50 Years of Keystone Symposia: Evolution of Scientific Programming
By Ralph A. Bradshaw
What is now the Keystone Symposia on Molecular and Cellular Biology, which...